Wolf Dale B's Form 4 filing
AdaptHealth Corp. (AHCO) · filed Aug 10, 2026
- Accession no.
- 0001104659-26-093575
- Filed
- Aug 10, 2026, 8:02 PM ET
- Trade date
- Aug 6-7, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $244.6K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001104659-26-097053 (Aug 14, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wolf Dale BCIK 0001228861 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | PPurchaseAcquired | +20,000 | $6.37 | +$127,400 | 143,234 | Direct | |
| Aug 7, 2026 | Common Stock | PPurchaseAcquired | +20,000 | $5.86F1 | +$117,200 | 34,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Referenced by the price of 1 transaction in Table I.
Remarks
*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.